Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.05 | 49.81 |
PEG Ratio (TTM) | 0.08 | 0.31 |
P/S Ratio (TTM) | 0.27 | 3.71 |
P/B Ratio (TTM) | 1.44 | 2.62 |
P/FCF Ratio (TTM) | -0.90 | 35.98 |
Price to 5YR AVG Earnings Ratio | N/A | 52.53 |
Price to 5YR AVG FCF Ratio | N/A | 30.39 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -11.80% | 1.32% |
ROE (TTM) | -42.67% | -1.96% |
Net Profit Margin (TTM) | -8.76% | -1.52% |
ROIC 5YR AVG | N/A | 141.20% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -133.12% | -368.70% | N/A |
Revenue | 0.52% | 107.65% | N/A |
Net Income | -137.73% | -61.65% | N/A |
Cash Flow | -82.73% | -174.01% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 8.27 | 3.00 |
Quick Ratio (TTM) | 2.58 | 2.98 |
D/E Ratio (TTM) | 2.88 | 1.46 |
Interest Coverage (TTM) | -2.31 | -0.62 |
Piotroski F-Score | 5 | 5 |
Altman Z-Score | 0.91 | 4.18 |
LTL to 5YR AVG FCF | N/A | 51.87 |
Shares Outstanding Growth 5YR AVG | N/A | 67.11% |